Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch

Mumbai-based Cipla faces massive income tax demand of ₹774 crore over rule violations, including short deductions and disallowance of expenses, amid the launch of its new obesity drug.

CiplaIncome Tax DemandRule ViolationsObesity DrugPharmaceutical IndustryReal Estate MumbaiJul 16, 2024

Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch
Real Estate Mumbai:Cipla, a leading pharmaceutical company based in Mumbai, has been handed a massive income tax demand of ₹774 crore. The demand notice cites additional taxes for rule violations, including short deductions, weighted deductions, and disallowance of expenses. This development comes at a time when the company is preparing to launch a new obesity drug.

The income tax demand of ₹773.44 crore covers assessment years from 2015-16 to 2022-23, excluding any tax refunds. Cipla has confirmed the demand in its regulatory filings and plans to appeal against the tax order. The company has stated that the tax demands are not applicable under the law.

The tax authorities have cited rule violations, including short deductions, wherein the company deducted less tax than the rate mentioned in the provisions. Additionally, weighted deductions allowed for companies to invest in the development of knowledge and research capabilities were also disallowed, as well as expenses incurred for business operations.

Cipla is a well-established pharmaceutical company that has been operating in India for over 80 years. The company has a strong presence in the domestic market and exports its products to over 80 countries worldwide. Despite the income tax demand, Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally.

Information
Cipla is an Indian multinational pharmaceutical company that was founded in 1935. The company is headquartered in Mumbai and has a strong presence in the domestic market. Cipla is known for its innovative and affordable healthcare solutions and has a global footprint, with exports to over 80 countries.

Cipla is a leading pharmaceutical company that has been operating in India for over 80 years. The company is committed to providing innovative and affordable healthcare solutions to patients globally.

Frequently Asked Questions

What is the amount of income tax demand slapped on Cipla?

The income tax demand on Cipla is ₹774 crore.

What are the rule violations cited by the tax authorities?

The tax authorities have cited rule violations, including short deductions, weighted deductions, and disallowance of expenses.

What is Cipla's response to the income tax demand?

Cipla has stated that the tax demands are not applicable under the law and plans to appeal against the tax order.

What is the significance of the income tax demand on Cipla?

The income tax demand on Cipla is significant as it comes at a time when the company is preparing to launch a new obesity drug, and may impact its financial performance.

What is Cipla's commitment to its customers?

Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally, despite the income tax demand.

Related News Articles

India's Luxury Housing Market Sees 27% Growth in Jan-Jun 2024
Real Estate Pune

India's Luxury Housing Market Sees 27% Growth in Jan-Jun 2024

Luxury housing sales surge in top seven cities, with Delhi-NCR, Mumbai, and Hyderabad leading the way. Pune sees a significant 450% YoY increase in luxury sales.

July 19, 2024
Read Article
Maharashtra Govt Mulls Stamp Duty Concession to Revive Housing Market
real estate news

Maharashtra Govt Mulls Stamp Duty Concession to Revive Housing Market

The Maharashtra government is considering a stamp duty concession on property registration to boost housing sales in the state.

August 29, 2024
Read Article
The Resurgence of Indian Real Estate: Major Cities Witness Unprecedented Growth
Real Estate Pune

The Resurgence of Indian Real Estate: Major Cities Witness Unprecedented Growth

Pune and Bengaluru are leading the charge in India's real estate boom, with an estimated 130 million sq ft of new projects added to the market. The trend towards premium properties is reshaping the landscape of the industry.

November 3, 2024
Read Article
Bengaluru Real Estate Takes a Cool Turn After Stampede
Real Estate

Bengaluru Real Estate Takes a Cool Turn After Stampede

Bengaluru's real estate market, which saw a significant uptick in mid-2023, is now experiencing a cooldown. Rental inquiries and sales have both seen a downturn, with experts predicting a further correction in the coming months.

November 6, 2024
Read Article
Discover the Serenity of Woodland Grove: House and Lot for Sale in Hugo
Real Estate

Discover the Serenity of Woodland Grove: House and Lot for Sale in Hugo

Explore the last available lots at Woodland Grove in Hugo, offering a serene and peaceful living experience with flexible installment options up to 5 years.

March 15, 2025
Read Article
Q1 2025 Sees a 28% Decline in Housing Sales in Top 7 Cities - Real Estate Update
Real Estate Maharashtra

Q1 2025 Sees a 28% Decline in Housing Sales in Top 7 Cities - Real Estate Update

Real estate markets in the top 7 cities of India experienced a 28% year-on-year decline in housing sales during the first quarter of 2025. This significant drop reflects ongoing challenges in the sector, including economic uncertainty and regulatory changes.

March 28, 2025
Read Article